Who owns Lipocine?

Top Holders and Investors of Lipocine Stock

Find out what company owns Lipocine, who bought Lipocine this quarter, and who sold shares of Lipocine stock?

Fund or Company Name Number of Shares Valued At As Of
Ameriprise Financial 702400 $1.62M Mar 2019
Renaissance Technologies 495659 $966535 Jun 2019
Vanguard 480623 $1.08M Mar 2019
BlackRock 373047 $1.01M Sep 2019
Mercer Global Advisors 212203 $490188 Mar 2019
Geode Capital Management 177263 $409477 Mar 2019
Dimensional Fund Advisors 143667 $280150 Jun 2019
Northern Trust 50817 $99093 Jun 2019
Knoll Capital Management 50000 $116000 Mar 2019
Deutsche Bank Aktiengesellschaft 48600 $111780 Mar 2019
CalPERS 46000 $128800 Sep 2019
Quad Capital Management Advisors 44000 $124080 Sep 2019
FNY Investment Advisers 27049 $75196 Sep 2019
Susquehanna International 22257 $42956 Jun 2019
PanAgora Asset Management 22218 $43102 Jun 2019
Spark Investment Management 17700 $33984 Jun 2019
Two Sigma Investments 14626 $33932 Mar 2019
Group One Trading 14140 $27997 Jun 2019
Bank of New York Mellon 13848 $39051 Sep 2019
Cutler 13000 $36010 Sep 2019
State Street Corporation 12400 $29016 Mar 2019
Ladenburg Thalmann Financial Services 6650 $12967 Jun 2019
UBS Group AG 3235 $6987 Mar 2019
Jpmorgan Chase & Co 3000 $6000 Jun 2019
Morgan Stanley 2250 $4995 Mar 2019
Benjamin F. Edwards & Company 1500 $4005 Sep 2019
Advisor 1150 $2001 Jun 2019
Bank of America Corporation 1000 $2000 Mar 2019
Federated Investors 633 $1000 Mar 2019
Tower Research Capital 57 $0 Sep 2019
Bnp Paribas Arbitrage, Snc 4 $11 Sep 2019

Who sold Lipocine?

Fund Name Date Sold Shares Held Valued At
J. Goldman & Co Dec. 31, 2018 238428 $309956
Barclays Dec. 31, 2018 30200 $38958
Citadel Advisors March 31, 2019 29450 $68324
Simplex Trading June 30, 2019 3840 $6
Meeder Asset Management June 30, 2019 3408 $6986
Manchester Financial June 30, 2019 500 $1000